RNAZ ▼ -1.8% - TransCode Therapeutics, Inc.
$RNAZ RNAZ - TransCode Therapeutics to Present Phase 1a Clinical Trial Data for TTX-MC138 at ESMO Congress 2026
19-OCT-2026 08:04 AM ET
Share this post
More filings for $RNAZ
RNAZ ▼ -5.9% - TransCode Therapeutics, Inc.Sep 28, 2026RNAZ ▲ +6.8% - TransCode Therapeutics, Inc.Sep 22, 2026RNAZ ▼ -7.3% - TransCode Therapeutics, Inc.Sep 10, 2026RNAZ ▲ +16.6% - TransCode Therapeutics, Inc.Aug 31, 2026$RNAZ SEC Filing Update (03-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 3, 2026$RNAZ SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 28, 2026
View full $RNAZ filing history →💬 Comments
Loading comments…
Leave a comment